Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 2:30 AM ET

Date/Time Source News Release
05/29/2025 08:30 AM EDT Business Wire Lantern Pharma's LP-184 Shows Promising In Vivo Activity in Atypical Teratoid Rhabdoid Tumors (ATRT) at SNO Pediatric Conference, Further Validating Rare Pediatric Disease Designation and Pathway to Clinical Trials
05/15/2025 08:45 AM EDT Business Wire Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates
05/12/2025 09:00 AM EDT Business Wire Lantern Pharma Secures FDA Clearance for Planned Phase 1b/2 Trial of LP-184 in Biomarker-Defined, Treatment-Resistant NSCLC Patients with High Unmet Clinical Need
05/08/2025 08:30 AM EDT Business Wire Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET
05/05/2025 08:55 AM EDT Business Wire Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)
03/27/2025 04:01 PM EDT Business Wire Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results
03/20/2025 08:00 AM EDT Business Wire Lantern Pharma to Report Fourth Quarter and Fiscal Year 2024 Operating & Financial Results on March 27th, 2025 at 4:30 p.m. ET
02/19/2025 08:00 AM EST Business Wire Lantern Pharma Announces PCT Patent Application Publication for Innovative, High Performing, Machine Learning Model for Predicting Blood Brain Barrier Permeability of Drug-Candidates
01/27/2025 07:55 AM EST Business Wire Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer
12/09/2024 08:15 AM EST Business Wire Lantern Pharma Announces First Patient Enrolled in Taiwan for Phase 2 HARMONIC(TM) Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
Page